Johnson & Johnson (NYSE:JNJ) will begin trading ex-dividend on August 24, 2020. The 3Q20 dividend payment of $ 1.01 per share is scheduled to be paid on September 8, 2020. Shareholders who purchased JNJ prior to the ex-dividend date are eligible for the cash dividend payment.
Dividends History
wpDataTable with provided ID not found!Click Here For More Historical Dividends Of Johnson & Johnson
Stock Performance
On Friday, shares of Johnson & Johnson has traded high as $ 153.65 and has cracked $ 150.59 on the downward trend, reaching $ 152.76 with volume of 6.72 million shares.
According to the previous trading day, closing price of $ 151.42, representing a 38.71 % increase from the 52 week low of $ 109.16 and a 3.55 % decrease over the 52 week high of $ 157.00.
The company has a market capital of $ 402.19 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
